▶ 調査レポート

世界の固相ペプチド合成装置(SPPS)市場(~2028年):自動、半自動

• 英文タイトル:Global Solid Phase Peptide Synthesizers (SPPS) Market Insights, Forecast to 2028

Global Solid Phase Peptide Synthesizers (SPPS) Market Insights, Forecast to 2028「世界の固相ペプチド合成装置(SPPS)市場(~2028年):自動、半自動」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2Q12-16422
• 出版社/出版日:QYResearch / 2022年12月
• レポート形態:英文、PDF、93ページ
• 納品方法:Eメール(納期:3営業日)
• 産業分類:産業機械&装置
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、固相ペプチド合成装置(SPPS)のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。
固相ペプチド合成装置(SPPS)のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
固相ペプチド合成装置(SPPS)の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
固相ペプチド合成装置(SPPS)のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。

生産面において、本レポートは2017年から2022年までの固相ペプチド合成装置(SPPS)の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の固相ペプチド合成装置(SPPS)の売上および2028年までの予測に焦点を当てています。

固相ペプチド合成装置(SPPS)のグローバル主要企業には、Büchi AG、AAPPTec、CEM、Gyros Protein Technologies、Biotage、CSBioなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

固相ペプチド合成装置(SPPS)市場は、タイプとアプリケーションによって区分されます。世界の固相ペプチド合成装置(SPPS)市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。

【タイプ別セグメント】
自動、半自動

【アプリケーション別セグメント】
製薬産業、化学産業、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 固相ペプチド合成装置(SPPS)製品概要
- タイプ別市場(自動、半自動)
- アプリケーション別市場(製薬産業、化学産業、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界の固相ペプチド合成装置(SPPS)販売量予測2017-2028
- 世界の固相ペプチド合成装置(SPPS)売上予測2017-2028
- 固相ペプチド合成装置(SPPS)の地域別販売量
- 固相ペプチド合成装置(SPPS)の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別固相ペプチド合成装置(SPPS)販売量
- 主要メーカー別固相ペプチド合成装置(SPPS)売上
- 主要メーカー別固相ペプチド合成装置(SPPS)価格
- 競争状況の分析
- 企業M&A動向
・タイプ別市場規模(自動、半自動)
- 固相ペプチド合成装置(SPPS)のタイプ別販売量
- 固相ペプチド合成装置(SPPS)のタイプ別売上
- 固相ペプチド合成装置(SPPS)のタイプ別価格
・アプリケーション別市場規模(製薬産業、化学産業、その他)
- 固相ペプチド合成装置(SPPS)のアプリケーション別販売量
- 固相ペプチド合成装置(SPPS)のアプリケーション別売上
- 固相ペプチド合成装置(SPPS)のアプリケーション別価格
・北米市場
- 北米の固相ペプチド合成装置(SPPS)市場規模(タイプ別、アプリケーション別)
- 主要国別の固相ペプチド合成装置(SPPS)市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの固相ペプチド合成装置(SPPS)市場規模(タイプ別、アプリケーション別)
- 主要国別の固相ペプチド合成装置(SPPS)市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の固相ペプチド合成装置(SPPS)市場規模(タイプ別、アプリケーション別)
- 主要国別の固相ペプチド合成装置(SPPS)市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の固相ペプチド合成装置(SPPS)市場規模(タイプ別、アプリケーション別)
- 主要国別の固相ペプチド合成装置(SPPS)市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの固相ペプチド合成装置(SPPS)市場規模(タイプ別、アプリケーション別)
- 主要国別の固相ペプチド合成装置(SPPS)市場規模(トルコ、サウジアラビア)
・企業情報
Büchi AG、AAPPTec、CEM、Gyros Protein Technologies、Biotage、CSBio
・産業チェーン及び販売チャネル分析
- 固相ペプチド合成装置(SPPS)の産業チェーン分析
- 固相ペプチド合成装置(SPPS)の原材料
- 固相ペプチド合成装置(SPPS)の生産プロセス
- 固相ペプチド合成装置(SPPS)の販売及びマーケティング
- 固相ペプチド合成装置(SPPS)の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 固相ペプチド合成装置(SPPS)の産業動向
- 固相ペプチド合成装置(SPPS)のマーケットドライバー
- 固相ペプチド合成装置(SPPS)の課題
- 固相ペプチド合成装置(SPPS)の阻害要因
・主な調査結果

Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Solid Phase Peptide Synthesizers (SPPS) estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Solid Phase Peptide Synthesizers (SPPS) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Solid Phase Peptide Synthesizers (SPPS) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Solid Phase Peptide Synthesizers (SPPS) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Solid Phase Peptide Synthesizers (SPPS) include Büchi AG, AAPPTec, CEM, Gyros Protein Technologies, Biotage and CSBio, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Solid Phase Peptide Synthesizers (SPPS) production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Solid Phase Peptide Synthesizers (SPPS) by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Report Scope
This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Solid Phase Peptide Synthesizers (SPPS) manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Solid Phase Peptide Synthesizers (SPPS) market. Further, it explains the major drivers and regional dynamics of the global Solid Phase Peptide Synthesizers (SPPS) market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Büchi AG
AAPPTec
CEM
Gyros Protein Technologies
Biotage
CSBio
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.
Solid Phase Peptide Synthesizers (SPPS) Segment by Type
Automated
Semi-automatic
Solid Phase Peptide Synthesizers (SPPS) Segment by Application
Pharmaceutical Industry
Chemical Industry
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the Solid Phase Peptide Synthesizers (SPPS) production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Solid Phase Peptide Synthesizers (SPPS) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Solid Phase Peptide Synthesizers (SPPS), capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Solid Phase Peptide Synthesizers (SPPS), also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Solid Phase Peptide Synthesizers (SPPS), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Solid Phase Peptide Synthesizers (SPPS) sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Solid Phase Peptide Synthesizers (SPPS) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Solid Phase Peptide Synthesizers (SPPS) sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Büchi AG, AAPPTec, CEM, Gyros Protein Technologies, Biotage and CSBio, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Solid Phase Peptide Synthesizers (SPPS) capacity, production/output of global and key producers (regions/countries). It provides a quantitative analysis of the capacity, production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Solid Phase Peptide Synthesizers (SPPS) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Solid Phase Peptide Synthesizers (SPPS) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by type, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 9: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 10: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Solid Phase Peptide Synthesizers (SPPS) sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.

レポート目次

1 Study Coverage
1.1 Solid Phase Peptide Synthesizers (SPPS) Product Introduction
1.2 Market by Type
1.2.1 Global Solid Phase Peptide Synthesizers (SPPS) Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Automated
1.2.3 Semi-automatic
1.3 Market by Application
1.3.1 Global Solid Phase Peptide Synthesizers (SPPS) Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical Industry
1.3.3 Chemical Industry
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Solid Phase Peptide Synthesizers (SPPS) Production
2.1 Global Solid Phase Peptide Synthesizers (SPPS) Production Capacity (2017-2028)
2.2 Global Solid Phase Peptide Synthesizers (SPPS) Production by Region: 2017 VS 2021 VS 2028
2.3 Global Solid Phase Peptide Synthesizers (SPPS) Production by Region
2.3.1 Global Solid Phase Peptide Synthesizers (SPPS) Historic Production by Region (2017-2022)
2.3.2 Global Solid Phase Peptide Synthesizers (SPPS) Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Solid Phase Peptide Synthesizers (SPPS) Sales in Volume & Value Estimates and Forecasts
3.1 Global Solid Phase Peptide Synthesizers (SPPS) Sales Estimates and Forecasts 2017-2028
3.2 Global Solid Phase Peptide Synthesizers (SPPS) Revenue Estimates and Forecasts 2017-2028
3.3 Global Solid Phase Peptide Synthesizers (SPPS) Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Solid Phase Peptide Synthesizers (SPPS) Sales by Region
3.4.1 Global Solid Phase Peptide Synthesizers (SPPS) Sales by Region (2017-2022)
3.4.2 Global Sales Solid Phase Peptide Synthesizers (SPPS) by Region (2023-2028)
3.5 Global Solid Phase Peptide Synthesizers (SPPS) Revenue by Region
3.5.1 Global Solid Phase Peptide Synthesizers (SPPS) Revenue by Region (2017-2022)
3.5.2 Global Solid Phase Peptide Synthesizers (SPPS) Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Solid Phase Peptide Synthesizers (SPPS) Production Capacity by Manufacturers
4.2 Global Solid Phase Peptide Synthesizers (SPPS) Sales by Manufacturers
4.2.1 Global Solid Phase Peptide Synthesizers (SPPS) Sales by Manufacturers (2017-2022)
4.2.2 Global Solid Phase Peptide Synthesizers (SPPS) Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Solid Phase Peptide Synthesizers (SPPS) in 2021
4.3 Global Solid Phase Peptide Synthesizers (SPPS) Revenue by Manufacturers
4.3.1 Global Solid Phase Peptide Synthesizers (SPPS) Revenue by Manufacturers (2017-2022)
4.3.2 Global Solid Phase Peptide Synthesizers (SPPS) Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Solid Phase Peptide Synthesizers (SPPS) Revenue in 2021
4.4 Global Solid Phase Peptide Synthesizers (SPPS) Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Solid Phase Peptide Synthesizers (SPPS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Solid Phase Peptide Synthesizers (SPPS) Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Solid Phase Peptide Synthesizers (SPPS) Sales by Type
5.1.1 Global Solid Phase Peptide Synthesizers (SPPS) Historical Sales by Type (2017-2022)
5.1.2 Global Solid Phase Peptide Synthesizers (SPPS) Forecasted Sales by Type (2023-2028)
5.1.3 Global Solid Phase Peptide Synthesizers (SPPS) Sales Market Share by Type (2017-2028)
5.2 Global Solid Phase Peptide Synthesizers (SPPS) Revenue by Type
5.2.1 Global Solid Phase Peptide Synthesizers (SPPS) Historical Revenue by Type (2017-2022)
5.2.2 Global Solid Phase Peptide Synthesizers (SPPS) Forecasted Revenue by Type (2023-2028)
5.2.3 Global Solid Phase Peptide Synthesizers (SPPS) Revenue Market Share by Type (2017-2028)
5.3 Global Solid Phase Peptide Synthesizers (SPPS) Price by Type
5.3.1 Global Solid Phase Peptide Synthesizers (SPPS) Price by Type (2017-2022)
5.3.2 Global Solid Phase Peptide Synthesizers (SPPS) Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Solid Phase Peptide Synthesizers (SPPS) Sales by Application
6.1.1 Global Solid Phase Peptide Synthesizers (SPPS) Historical Sales by Application (2017-2022)
6.1.2 Global Solid Phase Peptide Synthesizers (SPPS) Forecasted Sales by Application (2023-2028)
6.1.3 Global Solid Phase Peptide Synthesizers (SPPS) Sales Market Share by Application (2017-2028)
6.2 Global Solid Phase Peptide Synthesizers (SPPS) Revenue by Application
6.2.1 Global Solid Phase Peptide Synthesizers (SPPS) Historical Revenue by Application (2017-2022)
6.2.2 Global Solid Phase Peptide Synthesizers (SPPS) Forecasted Revenue by Application (2023-2028)
6.2.3 Global Solid Phase Peptide Synthesizers (SPPS) Revenue Market Share by Application (2017-2028)
6.3 Global Solid Phase Peptide Synthesizers (SPPS) Price by Application
6.3.1 Global Solid Phase Peptide Synthesizers (SPPS) Price by Application (2017-2022)
6.3.2 Global Solid Phase Peptide Synthesizers (SPPS) Price Forecast by Application (2023-2028)
7 North America
7.1 North America Solid Phase Peptide Synthesizers (SPPS) Market Size by Type
7.1.1 North America Solid Phase Peptide Synthesizers (SPPS) Sales by Type (2017-2028)
7.1.2 North America Solid Phase Peptide Synthesizers (SPPS) Revenue by Type (2017-2028)
7.2 North America Solid Phase Peptide Synthesizers (SPPS) Market Size by Application
7.2.1 North America Solid Phase Peptide Synthesizers (SPPS) Sales by Application (2017-2028)
7.2.2 North America Solid Phase Peptide Synthesizers (SPPS) Revenue by Application (2017-2028)
7.3 North America Solid Phase Peptide Synthesizers (SPPS) Sales by Country
7.3.1 North America Solid Phase Peptide Synthesizers (SPPS) Sales by Country (2017-2028)
7.3.2 North America Solid Phase Peptide Synthesizers (SPPS) Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Solid Phase Peptide Synthesizers (SPPS) Market Size by Type
8.1.1 Europe Solid Phase Peptide Synthesizers (SPPS) Sales by Type (2017-2028)
8.1.2 Europe Solid Phase Peptide Synthesizers (SPPS) Revenue by Type (2017-2028)
8.2 Europe Solid Phase Peptide Synthesizers (SPPS) Market Size by Application
8.2.1 Europe Solid Phase Peptide Synthesizers (SPPS) Sales by Application (2017-2028)
8.2.2 Europe Solid Phase Peptide Synthesizers (SPPS) Revenue by Application (2017-2028)
8.3 Europe Solid Phase Peptide Synthesizers (SPPS) Sales by Country
8.3.1 Europe Solid Phase Peptide Synthesizers (SPPS) Sales by Country (2017-2028)
8.3.2 Europe Solid Phase Peptide Synthesizers (SPPS) Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Solid Phase Peptide Synthesizers (SPPS) Market Size by Type
9.1.1 Asia Pacific Solid Phase Peptide Synthesizers (SPPS) Sales by Type (2017-2028)
9.1.2 Asia Pacific Solid Phase Peptide Synthesizers (SPPS) Revenue by Type (2017-2028)
9.2 Asia Pacific Solid Phase Peptide Synthesizers (SPPS) Market Size by Application
9.2.1 Asia Pacific Solid Phase Peptide Synthesizers (SPPS) Sales by Application (2017-2028)
9.2.2 Asia Pacific Solid Phase Peptide Synthesizers (SPPS) Revenue by Application (2017-2028)
9.3 Asia Pacific Solid Phase Peptide Synthesizers (SPPS) Sales by Region
9.3.1 Asia Pacific Solid Phase Peptide Synthesizers (SPPS) Sales by Region (2017-2028)
9.3.2 Asia Pacific Solid Phase Peptide Synthesizers (SPPS) Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Solid Phase Peptide Synthesizers (SPPS) Market Size by Type
10.1.1 Latin America Solid Phase Peptide Synthesizers (SPPS) Sales by Type (2017-2028)
10.1.2 Latin America Solid Phase Peptide Synthesizers (SPPS) Revenue by Type (2017-2028)
10.2 Latin America Solid Phase Peptide Synthesizers (SPPS) Market Size by Application
10.2.1 Latin America Solid Phase Peptide Synthesizers (SPPS) Sales by Application (2017-2028)
10.2.2 Latin America Solid Phase Peptide Synthesizers (SPPS) Revenue by Application (2017-2028)
10.3 Latin America Solid Phase Peptide Synthesizers (SPPS) Sales by Country
10.3.1 Latin America Solid Phase Peptide Synthesizers (SPPS) Sales by Country (2017-2028)
10.3.2 Latin America Solid Phase Peptide Synthesizers (SPPS) Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Solid Phase Peptide Synthesizers (SPPS) Market Size by Type
11.1.1 Middle East and Africa Solid Phase Peptide Synthesizers (SPPS) Sales by Type (2017-2028)
11.1.2 Middle East and Africa Solid Phase Peptide Synthesizers (SPPS) Revenue by Type (2017-2028)
11.2 Middle East and Africa Solid Phase Peptide Synthesizers (SPPS) Market Size by Application
11.2.1 Middle East and Africa Solid Phase Peptide Synthesizers (SPPS) Sales by Application (2017-2028)
11.2.2 Middle East and Africa Solid Phase Peptide Synthesizers (SPPS) Revenue by Application (2017-2028)
11.3 Middle East and Africa Solid Phase Peptide Synthesizers (SPPS) Sales by Country
11.3.1 Middle East and Africa Solid Phase Peptide Synthesizers (SPPS) Sales by Country (2017-2028)
11.3.2 Middle East and Africa Solid Phase Peptide Synthesizers (SPPS) Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Büchi AG
12.1.1 Büchi AG Corporation Information
12.1.2 Büchi AG Overview
12.1.3 Büchi AG Solid Phase Peptide Synthesizers (SPPS) Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Büchi AG Solid Phase Peptide Synthesizers (SPPS) Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Büchi AG Recent Developments
12.2 AAPPTec
12.2.1 AAPPTec Corporation Information
12.2.2 AAPPTec Overview
12.2.3 AAPPTec Solid Phase Peptide Synthesizers (SPPS) Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 AAPPTec Solid Phase Peptide Synthesizers (SPPS) Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 AAPPTec Recent Developments
12.3 CEM
12.3.1 CEM Corporation Information
12.3.2 CEM Overview
12.3.3 CEM Solid Phase Peptide Synthesizers (SPPS) Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 CEM Solid Phase Peptide Synthesizers (SPPS) Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 CEM Recent Developments
12.4 Gyros Protein Technologies
12.4.1 Gyros Protein Technologies Corporation Information
12.4.2 Gyros Protein Technologies Overview
12.4.3 Gyros Protein Technologies Solid Phase Peptide Synthesizers (SPPS) Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Gyros Protein Technologies Solid Phase Peptide Synthesizers (SPPS) Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Gyros Protein Technologies Recent Developments
12.5 Biotage
12.5.1 Biotage Corporation Information
12.5.2 Biotage Overview
12.5.3 Biotage Solid Phase Peptide Synthesizers (SPPS) Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Biotage Solid Phase Peptide Synthesizers (SPPS) Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Biotage Recent Developments
12.6 CSBio
12.6.1 CSBio Corporation Information
12.6.2 CSBio Overview
12.6.3 CSBio Solid Phase Peptide Synthesizers (SPPS) Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 CSBio Solid Phase Peptide Synthesizers (SPPS) Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 CSBio Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Solid Phase Peptide Synthesizers (SPPS) Industry Chain Analysis
13.2 Solid Phase Peptide Synthesizers (SPPS) Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Solid Phase Peptide Synthesizers (SPPS) Production Mode & Process
13.4 Solid Phase Peptide Synthesizers (SPPS) Sales and Marketing
13.4.1 Solid Phase Peptide Synthesizers (SPPS) Sales Channels
13.4.2 Solid Phase Peptide Synthesizers (SPPS) Distributors
13.5 Solid Phase Peptide Synthesizers (SPPS) Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Solid Phase Peptide Synthesizers (SPPS) Industry Trends
14.2 Solid Phase Peptide Synthesizers (SPPS) Market Drivers
14.3 Solid Phase Peptide Synthesizers (SPPS) Market Challenges
14.4 Solid Phase Peptide Synthesizers (SPPS) Market Restraints
15 Key Finding in The Global Solid Phase Peptide Synthesizers (SPPS) Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer